• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Core Scientific Inc.

    3/12/26 12:55:20 PM ET
    $CORZ
    Finance: Consumer Services
    Finance
    Get the next $CORZ alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    Core Scientific, Inc.

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)




    03/10/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP Number(s):


    1Names of Reporting Persons

    Valiant Capital Management, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    16,212,903.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    16,212,903.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    16,212,903.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.1 %
    12Type of Reporting Person (See Instructions)

    IA, PN

    Comment for Type of Reporting Person:  Percentage calculated based on 315,332,655 shares of Common Stock outstanding as of February 26, 2026, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2025.


    SCHEDULE 13G

    CUSIP Number(s):


    1Names of Reporting Persons

    Valiant Capital Management, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    16,212,903.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    16,212,903.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    16,212,903.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.1 %
    12Type of Reporting Person (See Instructions)

    HC, OO

    Comment for Type of Reporting Person:  Percentage calculated based on 315,332,655 shares of Common Stock outstanding as of February 26, 2026, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2025.


    SCHEDULE 13G

    CUSIP Number(s):


    1Names of Reporting Persons

    Christopher R. Hansen
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    16,212,903.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    16,212,903.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    16,212,903.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.1 %
    12Type of Reporting Person (See Instructions)

    HC, IN

    Comment for Type of Reporting Person:  Percentage calculated based on 315,332,655 shares of Common Stock outstanding as of February 26, 2026, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2025.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Core Scientific, Inc.
    (b)Address of issuer's principal executive offices:

    838 Walker Road, Suite 21-2105, Dover, DE 19904
    Item 2. 
    (a)Name of person filing:

    Valiant Capital Management, L.P., a Delaware limited partnership ("VCM") Valiant Capital Management, LLC, a Delaware limited liability company ("VCM LLC") Christopher R. Hansen VCM is the investment adviser and general partner of private investment funds (collectively, the "Funds") and the investment adviser to other accounts. VCM LLC is the general partner of VCM. Mr. Hansen is the control person of VCM and VCM LLC. The reporting persons are filing this Schedule 13G jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therein.
    (b)Address or principal business office or, if none, residence:

    394 Pacific Avenue, Floor 4, San Francisco, CA 94111
    (c)Citizenship:

    See Item 4 of the cover sheet for each reporting person
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    21874A106
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    VCM: 16,212,903 VCM LLC: 16,212,903 Christopher R. Hansen: 16,212,903
    (b)Percent of class:

    VCM: 5.1% VCM LLC: 5.1% Christopher R. Hansen: 5.1%
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    VCM: 0 VCM LLC: 0 Christopher R. Hansen: 0

     (ii) Shared power to vote or to direct the vote:

    VCM: 16,212,903 VCM LLC: 16,212,903 Christopher R. Hansen: 16,212,903

     (iii) Sole power to dispose or to direct the disposition of:

    VCM: 0 VCM LLC: 0 Christopher R. Hansen: 0

     (iv) Shared power to dispose or to direct the disposition of:

    VCM: 16,212,903 VCM LLC: 16,212,903 Christopher R. Hansen: 16,212,903

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The Funds hold the Common Stock for the benefit of their investors and have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock. No individual Fund's holdings of Common Stock are more than five percent of the outstanding Common Stock.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Valiant Capital Management, L.P.
     
    Signature:/s/ Michaela Beckman
    Name/Title:Chief Compliance Officer
    Date:03/12/2026
     
    Valiant Capital Management, LLC
     
    Signature:/s/ Michaela Beckman
    Name/Title:Chief Compliance Officer
    Date:03/12/2026
     
    Christopher R. Hansen
     
    Signature:/s/ Christopher R. Hansen
    Name/Title:Reporting person
    Date:03/12/2026
    Exhibit Information

    Exhibit 99 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G

    Get the next $CORZ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CORZ

    DatePrice TargetRatingAnalyst
    3/3/2026$23.00Hold → Buy
    Needham
    1/6/2026$23.00Neutral → Buy
    BTIG Research
    12/18/2025$30.00Mkt Perform → Mkt Outperform
    Citizens JMP
    10/28/2025$25.00Neutral → Buy
    H.C. Wainwright
    10/23/2025$23.50Neutral → Buy
    Roth Capital
    10/22/2025$30.00Neutral → Buy
    B. Riley Securities
    9/15/2025Buy
    Compass Point
    7/22/2025$20.00Buy
    Arete
    More analyst ratings

    $CORZ
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Core Scientific Inc.

    SCHEDULE 13G - Core Scientific, Inc./tx (0001839341) (Subject)

    3/12/26 12:55:20 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Core Scientific Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Core Scientific, Inc./tx (0001839341) (Filer)

    3/6/26 4:13:50 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SCHEDULE 13D/A filed by Core Scientific Inc.

    SCHEDULE 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

    3/4/26 9:05:37 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $CORZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cadillac Formula 1® Team Joins Forces with Core Scientific as Official Data Center Partner

    Core Scientific and Cadillac Formula 1® Team Announce a Multi-Year Global Partnership Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation, and Cadillac Formula 1® Team have announced a multi-year global partnership, naming Core Scientific as the team's Official Data Center Partner. Core Scientific will play a central role in advising and shaping the team's data center infrastructure in its new U.S. headquarters, currently under construction in Indianapolis, Indiana. Through this partnership, Core Scientific will provide strategic consulting, architectural guidance and optimization expertise to ensure th

    3/10/26 8:00:00 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Core Scientific Secures Strategic Financing with Morgan Stanley for Up To $1 Billion

    Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation, today announced that it completed the initial closing of a $500 million 364-day loan facility (the "Facility") provided by Morgan Stanley. The Facility includes an accordion feature that provides the potential to increase total commitments by up to an additional $500 million, for total commitments of up to $1.0 billion, subject to customary terms and conditions. Borrowings under the Facility bear interest at a rate of Secured Overnight Financing Rate ("SOFR") plus 250 basis points (2.50%). "This strengthens our liquidity and enhances our financial flexi

    3/5/26 7:00:00 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Core Scientific Announces Fourth Quarter Fiscal Year 2025 Results

    Key Highlights New Top-market Site: Announced an agreement to expand into Hunt County, Texas, which is expected to support ~430 MW of gross power capacity, with an approved ERCOT interconnection ramp schedule. Power Expansion at Existing Locations: Increased gross power capacity by ~300 MW across Dalton, Georgia and Pecos, Texas. Continued Execution on CoreWeave Contract: To date, energized ~350 MW of power and remain on track to deliver ~590 MW by early 2027. Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-density colocation services, today announced financial results for the fourth quarter of 2025. "We're now past the halfway point on our e

    3/2/26 4:10:00 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $CORZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Weiss Eric Stanton bought $101,700 worth of shares (7,000 units at $14.53), increasing direct ownership by 3% to 252,262 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    3/10/26 4:08:53 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Director Booth Jeffrey David was granted 18,575 shares, increasing direct ownership by 9% to 214,262 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    2/6/26 4:11:54 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Director Crain Elizabeth was granted 18,575 shares, increasing direct ownership by 40% to 65,348 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    2/6/26 4:11:51 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $CORZ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Weiss Eric Stanton bought $101,700 worth of shares (7,000 units at $14.53), increasing direct ownership by 3% to 252,262 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    3/10/26 4:08:53 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Director Weiss Eric Stanton bought $107,500 worth of shares (5,000 units at $21.50), increasing direct ownership by 2% to 226,687 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    11/6/25 4:25:01 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Director Rozov Yadin bought $1,195,370 worth of shares (110,000 units at $10.87), increasing direct ownership by 30% to 475,687 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    5/29/25 4:14:21 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $CORZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Core Scientific upgraded by Needham with a new price target

    Needham upgraded Core Scientific from Hold to Buy and set a new price target of $23.00

    3/3/26 10:31:14 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Core Scientific upgraded by BTIG Research with a new price target

    BTIG Research upgraded Core Scientific from Neutral to Buy and set a new price target of $23.00

    1/6/26 8:25:34 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Core Scientific upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Core Scientific from Mkt Perform to Mkt Outperform and set a new price target of $30.00

    12/18/25 8:41:18 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $CORZ
    Leadership Updates

    Live Leadership Updates

    View All

    BluSky AI Inc. Appoints Riley Cooney as Corporate Development and Strategy Officer

    Salt Lake City Utah, Dec. 09, 2025 (GLOBE NEWSWIRE) -- BluSky AI Inc. (OTCID: BSAI), a leading developer of prefabricated modular AI infrastructure and Neocloud GPU-as-a-Service infrastructure, proudly announces the appointment of Riley Cooney as its Corporate Development and Strategy Officer. Cooney is a well-respected FP&A and strategic finance executive whose experience includes leadership through a $4B IPO in BTC and Hyperscale infrastructure. Riley has advised on AI and HPC data-center strategy, serving global institutional and Wall Street clients over the past two years. During his five years at Core Scientific (NASDAQ:CORZ), Riley helped scale revenue 24× while growing power capaci

    12/9/25 1:37:56 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Two Seas Capital Expresses Enthusiasm for Core Scientific's Future Prospects

    Issues Letter to Shareholders Highlighting Significant Upside Potential If Proposed Sale to CoreWeave Is Not Approved Urges Shareholders to Vote AGAINST the Ill-Advised Transaction on the GOLD Proxy Card Ahead of October 30, 2025 Special Meeting NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today issued a letter to shareholders in connection with its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) on the terms announced on July 7, 2025.

    10/28/25 8:30:00 AM ET
    $CORZ
    $CRWV
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    /C O R R E C T I O N -- Two Seas Capital/

    In the news release, Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave, issued 17-Oct-2025 by Two Seas Capital over PR Newswire, three charts were inadvertently excluded by PR Newswire. The release, with the accompanying charts and the full pdf letter, follows: Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW

    10/17/25 9:00:00 AM ET
    $CORZ
    $CRWV
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    $CORZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Core Scientific Inc.

    SC 13G - Core Scientific, Inc./tx (0001839341) (Subject)

    8/19/24 7:14:21 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    SEC Form SC 13D/A filed by Core Scientific Inc. (Amendment)

    SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

    2/21/24 4:43:56 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    SEC Form SC 13D/A filed by Core Scientific Inc. (Amendment)

    SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

    2/20/24 5:19:03 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $CORZ
    Financials

    Live finance-specific insights

    View All

    Core Scientific Announces Fourth Quarter Fiscal Year 2025 Results

    Key Highlights New Top-market Site: Announced an agreement to expand into Hunt County, Texas, which is expected to support ~430 MW of gross power capacity, with an approved ERCOT interconnection ramp schedule. Power Expansion at Existing Locations: Increased gross power capacity by ~300 MW across Dalton, Georgia and Pecos, Texas. Continued Execution on CoreWeave Contract: To date, energized ~350 MW of power and remain on track to deliver ~590 MW by early 2027. Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-density colocation services, today announced financial results for the fourth quarter of 2025. "We're now past the halfway point on our e

    3/2/26 4:10:00 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Core Scientific, Inc. Schedules Fourth Quarter Fiscal Year 2025 Earnings Release, Conference Call and Webcast

    Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation, today announced it will release its fourth quarter and fiscal year 2025 financial results after the financial markets close on Monday, March 2, 2026. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the fourth quarter and fiscal year 2025 will be Adam Sullivan, Chief Executive Officer, Matt Brown, Chief Operating Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webc

    2/23/26 7:00:00 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Core Scientific to Host Investor Conference Call and Webcast Today at 11:30 AM Eastern Time

    Core Scientific, Inc. (NASDAQ:CORZ) ( "Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation services and digital asset mining, will host a conference call and live audio webcast with investors today at 11:30 A.M. Eastern Time. Hosting the call and webcast will be Adam Sullivan, Chief Executive Officer, Matt Brown, Chief Operating Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webcast Event Summary Date: October 30, 2025 Time: 11:30 AM EST Investors with Internet access may access the presentation and listen to the live audio webcast directly by clicking here o

    10/30/25 10:40:00 AM ET
    $CORZ
    Finance: Consumer Services
    Finance